The burgeoning popularity of retatrutide, initially for blood sugar control , is creating significant interest within the United Kingdom , prompting a notable shift in hormone trends. Obtaining these compounds remains a complex landscape, with public healthcare system coverage currently limited and specialist practices offering treatment at a highe